University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol

Exclusion Criteria

• •Presence of risk factors for or clinical evidence of Human immunodeficiency virus (type 1 and 2), Hepatitis B, Hepatitis C, Human T-lymphotrophic virus (type I and II), Human transmissible spongiform encephalopathy (including Creutzfeldt-Jakob disease) treponema pallidum,
• •Presence of communicable disease risk associated with xenotransplantation.
• •Test positive for Human immunodeficiency virus (type 1 and 2), Hepatitis B, Hepatitis C, Human T-lymphotrophic virus (type I and II), cytomegalovirus (CVM), West Nile Virus, treponema pallidum.
• •Use of investigational drug within 30 days or 5 half lives which ever is longer. Use of investigational implanted device.
• •History of malignancy.
• •Pregnancy
• •In the opinion of the hematologist or the investigator, a condition that compromises the ability of the donor to safely provide BM donation.